Health Canada approves Cytokinetics’ MYQORZO for obstructive HCM
Health Canada approved aficamten for adults with symptomatic obstructive hypertrophic cardiomyopathy.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.